Go to content
UR Home

Real world application of ocrelizumab in multiple sclerosis: Single-center experience of 128 patients

Prockl, Victoria ; Nickel, Florian T. ; Utz, Kathrin S. ; Fröhlich, Kilian ; Engelhorn, Tobias ; Hilz, Max-Josef ; Lee, De-Hyung ; Linker, Ralf A. ; Huhn, Konstantin


Background: Pivotal trials showed good clinical efficiency of the monoclonal antibody ocrelizumab while being well tolerated and manageable in multiple sclerosis (MS). However, data on adverse events in everyday practice are scarce. Hence, our study aims at investigating short-term tolerability of ocrelizumab in a "real-world" setting. Methods: In this retrospective cohort study, data of 128 (86 ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons